Japan’s pharmaceutical companies will not, however, be able to satisfy the nation’s needs completely.
China is supporting domestic pharmaceutical companies, such as CanSino Biologics, while Russia is racing to start inoculations ahead of the West.
Effective commitment to international cooperation will be crucial to making COVID-19 vaccines equally available worldwide.
China is showing interest in supplying COVID-19 vaccines through these channels.
The FDA and the WTO have already relaxed vaccine efficacy criteria, which normally demand 80-90% success rates.